Your doctor may determine your dosage of Humulin R using a sliding scale ... active ingredient insulin lispro. Humulin R is a short-acting insulin, while Humalog is a rapid-acting insulin.

A total daily dose (TDD) of insulin was determined based on patient-specific parameters. The TDD was then divided into a long-acting insulin (insulin glargine [0.4 × TDD]) and a short-acting ...

A fast-acting tow truck driver in Albany just missed being struck by a car while on the job Wednesday. Video obtained from AAA Hudson Valley shows the driver quickly hops onto his flatbed as the ...

The rapid-acting treatment is approved for the acute treatment of migraine episodes regardless of whether they are accompanied by aura, which are the sensory disturbances—mostly visual—that ...

Thus, we aimed at measuring the access to insulin in terms of their prices, availability, and affordability, in Pakistan. To the best of our knowledge, this is the first national scale study to ...

“Too many rules and rules proposals have the possibility for catastrophic outcomes for the applicant or practitioner.” I liked reading the always-excellent Rob Greenspoon’s post about five ...

If you cannot test, you should still treat for low blood sugar with fast-acting carbohydrates. Intentional insulin overdose is extremely dangerous and can lead to severe brain damage, coma, and death.

First fasting blood glucose on admission, mg/dL a 160.6 ± 75.2 206.3 ± 109.9 < 0.001 Total blood glucose, mg/dL a 185.6 ± 36.1 178.9 ± 54.3 0.002 ...

The National Concerned Small-Scale Miners Association of Ghana has congratulated Sammy Gyamfi on his recent appointment as the acting Managing Director of the Precious Minerals Marketing Company ...

With Zimmer removed as acting CIO, Energy leadership has appointed Ryan Riedel ... The U.S. AI Safety Institute has selected Scale AI as the first third-party evaluator authorized to assess AI models ...

has been awarded a $375 million project agreement through the Rapid Response Partnership Vehicle (RRPV), to advance the development of S-892216, a 3CL protease inhibitor, as a long-acting ...